NDC 63459-348 – Bendeka

Bendamustine Hydrochloride 25 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC63459-348

Product details

Brand name
Bendeka
Generic name
Bendamustine hydrochloride
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA208194
Marketed since
December 8, 2015
Listing expires
December 31, 2026
Pharmacologic class
Alkylating Drug

Active ingredients

Uses, dosage, side effects and warnings for Bendeka →

Package NDC codes (1)

Package NDCDescriptionSince
63459-348-041 VIAL, MULTI-DOSE in 1 CARTON (63459-348-04) / 4 mL in 1 VIAL, MULTI-DOSEDec 8, 2015